论文部分内容阅读
目的:分析厄贝沙坦联合硝苯地平控释片治疗高血压的临床疗效。方法:选取该院2013年4月至2015年12月收治的90例高血压患者作为调查对象,将其分为实验组与对照组各45例,对照组使用硝苯地平控释片治疗,实验组使用厄贝沙坦联合硝苯地平控释片治疗,对比两组患者治疗后的疗效。结果:实验组的治疗总有疗效为98.45%,明显高于对照组的(87.65%,P<0.05)。其中实验组患者的舒张压、收缩压等降低幅度明显要比对照组显著(P<0.05)。结论:对高血压患者采用厄贝沙坦联合硝苯地平控释片治疗,可显著降低其舒张压、收缩压,临床效果显著,值得推广使用。
Objective: To analyze the clinical efficacy of irbesartan and nifedipine GITS in the treatment of hypertension. Methods: Ninety patients with hypertension were selected from April 2013 to December 2015 in our hospital. The patients were divided into experimental group and control group (45 cases each). The control group was treated with nifedipine controlled release tablets The group treated with irbesartan combined with nifedipine controlled release tablets, compared two groups of patients after treatment. Results: The total effective rate of the experimental group was 98.45%, which was significantly higher than that of the control group (87.65%, P <0.05). The reduction of diastolic blood pressure and systolic blood pressure in the experimental group was significantly higher than that in the control group (P <0.05). Conclusion: Irbesartan combined with nifedipine controlled release tablets can significantly reduce diastolic blood pressure and systolic blood pressure in hypertensive patients, and its clinical effect is significant and worthy of promotion.